Product Description
| Specification |
2% |
Usage |
Anthelmintic / antiparasitic |
| Raw Material |
Ivermectin |
Species |
Cattle, sheep, swine, camels,chicken |
| Dosage Form |
Injection |
Sample |
Yes |
| Packing |
100ml/vial/box, 80boxes/carton
50ml/vial/box, 120boxes/carton
20ml/vial/box, 300boxes/carton
10ml/vial/box, 500boxes/carton |
Delivery Time |
15-20days |
| MOQ |
500L |
Payment Term |
T/T, D/P, D/A, L/C |
| GMP |
Yes |
ISO9001 |
Yes |
| FDA |
Yes |
COS |
Yes |
Ivermectin injection
Indication
Ivermectin injection is indicated for the effective treatment and control of parasites.
Pharmacology and Mechanism of Action
Antiparasitic: Avermectins (Ivermectin-like medicines) and milbemycins (milbemycin and moxidectin) are macrocyclic lactiones and share similarities, including mechanism of action. These products are neurotoxic to parasites by protentiating glutamate-gated chloride ion channels in parasites. Paralysis and death of the parasite are caused by increased permeability to chloride ions and hyperpolarization of nerve cells. These products also potentiate other chloride channesl, indlucing ones gated by GABA.
Mammals ordinarily are not affected because they lack glutamate-gated chloride channels, and there is a lower affinity for other mammalian chloride channels. Because these products ordinarily do not penetrate the blood-brain barrier, GABA-gated channels in the CNS of mammals are not affected. Ivermectin is active against intestinal parasites, mites, bots, heartworm microfilaria, and developing larvae.
Ivermectin can also produce heartworm adulticide effects when administered long-term. Ivermectin has no effect on trematode or cestode parasites.
Administration and Dosage:
Ivermectin should be administrated only by subcutaneous injection beneath the loose skin behind the shoulder.
1ml \ 50 kg
Withdrawal:
Cattle, Sheep must not be treated within 35Days of slaughter for human consumption.
Storage:
Protect from direct sunlight and store below 30°C.
Company Profile
Company introduction:
Hebei Veyong pharmaceutical Co., Ltd., was established in 2002, located in Shijiazhuang City Hebei Province, China, near the Capital Beijing. It's a large GMP-certified veterinary druo enterprise, with R&D, production and sales of veterinary APlspreparations premixed feeds and feed additives. As Provincial Technical CenterVeyong has established an innovated R&D system for new veterinary drug, and is the nationally knowntechnological innovation-based veterinary enterprise. Veyong has two production bases: Shijiazhuang and Ordos, with 7APl production lines including lvermectin, Eprinomectin, Tiamulin Fumarateects and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant ect. Veyong provides APls, more than 100 own-label preparations and OEM & ODM service.
Vevong established the comolete auality manaement svstem, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technica service, has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong attaches great importance to the management of EHS (Environment Health & Safety) system, and obtained the lSO14001 and OHSAS18001 certificates. Veyong ha been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply ofproducts.
Vevong takes "Maintain animal health, improve quality of life"as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
Certifications
Production workshop
Laboratory
Warehouse
Denetlenen Tedarikçi 
